99 related articles for article (PubMed ID: 9680240)
1. Neuroprotective effect of YM-39558 in focal cerebral ischemia in cats.
Akiho H; Iwai A; Tsukamoto S; Koshiya K; Yamaguchi T
Neuropharmacology; 1998; 37(2):159-68. PubMed ID: 9680240
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effect of YM90K, a novel AMPA/kainate receptor antagonist, in focal cerebral ischemia in cats.
Yatsugi S; Takahashi M; Kawasaki-Yatsugi S; Koshiya K; Sakamoto S; Uematsu D; Shimizu-Sasamata M
J Cereb Blood Flow Metab; 1996 Sep; 16(5):959-66. PubMed ID: 8784240
[TBL] [Abstract][Full Text] [Related]
3. YM872, a novel selective alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor antagonist, reduces brain damage after permanent focal cerebral ischemia in cats.
Takahashi M; Ni JW; Kawasaki-Yatsugi S; Toya T; Yatsugi SI; Shimizu-Sasamata M; Koshiya K; Shishikura JI; Sakamoto S; Yamaguchi T
J Pharmacol Exp Ther; 1998 Feb; 284(2):467-73. PubMed ID: 9454786
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of YM-39558, orotic acid ethylester, in gerbil forebrain ischemia.
Akiho H; Iwai A; Katoh-Sudoh M; Tsukamoto S; Koshiya K; Yamaguchi T
Jpn J Pharmacol; 1998 Apr; 76(4):441-4. PubMed ID: 9623724
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effect of the AMPA receptor antagonist LY-293558 in focal cerebral ischemia in the cat.
Bullock R; Graham DI; Swanson S; McCulloch J
J Cereb Blood Flow Metab; 1994 May; 14(3):466-71. PubMed ID: 8163588
[TBL] [Abstract][Full Text] [Related]
6. Focal cerebral ischemia in the cat: pretreatment with a kappa-1 opioid receptor agonist, CI-977.
Mackay KB; Kusumoto K; Graham DI; McCulloch J
Brain Res; 1993 Aug; 618(2):213-9. PubMed ID: 8397047
[TBL] [Abstract][Full Text] [Related]
7. AR-R15896AR reduces cerebral infarction volumes after focal ischemia in cats.
Sutherland GR; Perron JT; Kozlowski P; McCarthy DJ
Neurosurgery; 2000 Mar; 46(3):710-9; discussion 719-20. PubMed ID: 10719868
[TBL] [Abstract][Full Text] [Related]
8. Effects of ifenprodil, a polyamine site NMDA receptor antagonist, on reperfusion injury after transient focal cerebral ischemia.
Doğan A; Rao AM; Başkaya MK; Rao VL; Rastl J; Donaldson D; Dempsey RJ
J Neurosurg; 1997 Dec; 87(6):921-6. PubMed ID: 9384405
[TBL] [Abstract][Full Text] [Related]
9. Temporal characteristics of the protective effect of aminoguanidine on cerebral ischemic damage.
Zhang F; Iadecola C
Brain Res; 1998 Aug; 802(1-2):104-10. PubMed ID: 9748524
[TBL] [Abstract][Full Text] [Related]
10. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat.
Zhao Z; Cheng M; Maples KR; Ma JY; Buchan AM
Brain Res; 2001 Aug; 909(1-2):46-50. PubMed ID: 11478919
[TBL] [Abstract][Full Text] [Related]
11. Efficacious experimental stroke treatment with high-dose methylprednisolone.
de Courten-Myers GM; Kleinholz M; Wagner KR; Xi G; Myers RE
Stroke; 1994 Feb; 25(2):487-92; discussion 493. PubMed ID: 8303761
[TBL] [Abstract][Full Text] [Related]
12. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia.
Dawson DA; Graham DI; McCulloch J; Macrae IM
Br J Pharmacol; 1994 Sep; 113(1):247-53. PubMed ID: 7529111
[TBL] [Abstract][Full Text] [Related]
13. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia.
Yang Y; Li Q; Shuaib A
Exp Neurol; 2000 May; 163(1):39-45. PubMed ID: 10785442
[TBL] [Abstract][Full Text] [Related]
14. In vivo neuroprotective effects of ACEA 1021 confirmed by magnetic resonance imaging in ischemic stroke.
Petty MA; Neumann-Haefelin C; Kalisch J; Sarhan S; Wettstein JG; Juretschke HP
Eur J Pharmacol; 2003 Aug; 474(1):53-62. PubMed ID: 12909195
[TBL] [Abstract][Full Text] [Related]
15. Early administration of a second-generation perfluorochemical decreases ischemic brain damage in a model of permanent middle cerebral artery occlusion in the rat.
Woitzik J; Weinzierl N; Schilling L
Neurol Res; 2005 Jul; 27(5):509-15. PubMed ID: 15978177
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective activity of tamoxifen in permanent focal ischemia.
Kimelberg HK; Jin Y; Charniga C; Feustel PJ
J Neurosurg; 2003 Jul; 99(1):138-42. PubMed ID: 12854756
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective effects of erythropoietin pretreatment in a rodent model of transient middle cerebral artery occlusion.
Ratilal BO; Arroja MM; Rocha JP; Fernandes AM; Barateiro AP; Brites DM; Pinto RM; Sepodes BM; Mota-Filipe HD
J Neurosurg; 2014 Jul; 121(1):55-62. PubMed ID: 24702327
[TBL] [Abstract][Full Text] [Related]
18. Acute improvement in histological outcome by MK-801 following focal cerebral ischemia and reperfusion in the cat independent of blood flow changes.
Dezsi L; Greenberg JH; Hamar J; Sladky J; Karp A; Reivich M
J Cereb Blood Flow Metab; 1992 May; 12(3):390-9. PubMed ID: 1314841
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of the selective type 1 metabotropic glutamate receptor antagonist YM-202074 in rat stroke models.
Kohara A; Takahashi M; Yatsugi S; Tamura S; Shitaka Y; Hayashibe S; Kawabata S; Okada M
Brain Res; 2008 Jan; 1191():168-79. PubMed ID: 18164695
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of ifenprodil on ischemic injury size, blood-brain barrier breakdown, and edema formation in focal cerebral ischemia.
Başkaya MK; Rao AM; Donaldson D; Prasad MR; Dempsey RJ
Neurosurgery; 1997 Feb; 40(2):364-70; discussion 370-1. PubMed ID: 9007871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
